BIOSPAIN 2026

Spain is doubling down on early-stage innovation with the launch of the Innvierte Deep-Tech & Tech Transfer programme, led by CDTI Innovación under the Ministry of Science, Innovation and Universities (MICIU), in collaboration with the European Investment Fund. With a total allocation of €353 million targeting early-stage technologies (TRL 2–4), this initiative aims to close Spain’s critical funding gap between research and commercialization—unlocking the potential of universities, research centers, and spin-offs.
This round table will explore how public-private co-investment models—such as the recent €30 million commitment into the Montana Children’s Health fund managed by Ship2B Ventures—can catalyze a stronger deep-tech ecosystem. Panelists will discuss the role of institutional capital in de-risking early innovation, the challenges of tech transfer in Spain, and how to scale breakthrough science into globally competitive companies.
Key questions include: How can Spain better align financial instruments with the needs of deep-tech entrepreneurs? What lessons can be drawn from this first Innvierte transaction? And how can investors, corporates, and public actors collaborate to accelerate the journey from lab to market?
The session is designed for investors, fund managers, tech transfer offices, policymakers, and entrepreneurs seeking to understand and engage with Spain’s evolving deep-tech financing landscape.